Leverage Judi for increased compliance: expedited, high quality, structured decision-making on centralized patient eligibility determination that can eliminate an entire category of important protocol deviations from your trial
DownloadDownloadWhether you need to transmit and review solid tumor images for a pivotal Phase III Oncology trial, determine patient eligibility with a central review committee for a rare disease study, or collaborate with colleagues across the globe to reliably process clinical events for adjudication in an area with novel endpoints, Judi is the advantage more biopharmaceutical and medical device sponsors are trusting to support mission-critical process management.
Powering 2,400+ clinical trials across the world, including over 350 pivotal Phase III studies.
Judi has the flexibility required for any therapeutic area, phase, or level of complexity
From early stage to post-marketing registry trials, leading biopharma and medical device sponsors have relied on the flexibility of Judi to facilitate development of today’s leading medicines. See how Judi can help your clinical project or program below.
Experience
For over 20 years, AG Mednet has partnered with most of the world’s biopharmaceutical and medical device trial sponsors to advance and improve patient outcomes through successful clinical development.
Unmatched Flexibility
Unlike legacy "platform" providers, Judi was designed from the ground-up to solve for the dynamic variability of clinical conduct and process required in any phase or therapeutic area. Judi is always configured to adapt to your process—not ours.
Security and Compliance
Secure, compliant data management and audit trails provide the confidence of today’s regulatory environment. Judi is HIPAA, GDPR, SOC-2, and 21 CFR Part 11 compliant.
Partnering for Success
Leveraging the power and flexibility of Judi’s solutions has become a standard at most major biopharmaceutical and CRO entities. No matter the size, phase, or complexity of the clinical project or program, working with AG Mednet means you’ll have more than a technology partner, you’ll have an ally that values the nuances of your work as much as you do.


International biopharma sponsor and partner CRO maximize flexibility of Judi in DSMB for Phase 2 multinational clinical program with over 100 patients and 60 sites
DownloadDownload

